Centre for Cancer Biology, SA Pathology, Frome Road, Adelaide, SA 5000, Australia.
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):213-23. doi: 10.1007/s10911-010-9183-z. Epub 2010 May 25.
MicroRNAs are master regulators of gene expression in many biological and pathological processes, including mammary gland development and breast cancer. The differentiation program termed the epithelial to mesenchymal transition (EMT) involves changes in a number of microRNAs. Some of these microRNAs have been shown to control cellular plasticity through the suppression of EMT-inducers or to influence cellular phenotype through the suppression of genes involved in defining the epithelial and mesenchymal cell states. This has led to the suggestion that microRNAs maybe a novel therapeutic target for the treatment of breast cancer. In this review, we will discuss microRNAs that are involved in EMT in mammary cells and breast cancer.
MicroRNAs 是许多生物和病理过程中基因表达的主要调控因子,包括乳腺发育和乳腺癌。称为上皮间质转化 (EMT) 的分化程序涉及许多 microRNAs 的变化。其中一些 microRNAs 已被证明可以通过抑制 EMT 诱导剂来控制细胞可塑性,或者通过抑制参与定义上皮和间充质细胞状态的基因来影响细胞表型。这就提出了 microRNAs 可能是治疗乳腺癌的新的治疗靶点的建议。在这篇综述中,我们将讨论参与乳腺细胞和乳腺癌 EMT 的 microRNAs。